Latest News for: Business hangzhou

Edit

New all-cargo air route links Hangzhou, Miami

Xinhua 05 Apr 2024
HANGZHOU, April 5 ... It is the fourth all-cargo air route to and from the United States opened by the Hangzhou airport after New York, Los Angeles and Chicago.
Edit

Ingdan Announces 2023 Annual Results

Vietnam News 28 Mar 2024
Jeffrey Kang, CEO of Ingdan, Inc., said, "With the rapid development of AI and its applications expanding to various industries, the Group remains an optimistic outlook on business growth and development prospects this year.
Edit

Pet-friendly cafes make 'purrfect' combo

China Daily 28 Feb 2024
"There are so many coffee shops in Hangzhou ... At a pet-friendly cafe in Hangzhou's Hubin business area, a steady stream of coffee fans arrive for a cup of joe with their trusty four-legged friends in tow.
Edit

Alibaba Discloses More Chinese State Ownership in Business Units

Caixin Online 27 Feb 2024
disclosed a wider web of Chinese government stakes in its business units than previously known, following an inquiry by the U.S.
Edit

Alibaba reveals state stakes in 12 business units

Hong Kong Standard 26 Feb 2024
Alibaba (9988) disclosed a wider web of Chinese government stakes in its business units than previously known, following an inquiry from the US Securities and Exchange Commission. The Hangzhou-based ...
Edit

Founder of Chinese beverage giant dies at 79

Xinhua 25 Feb 2024
HANGZHOU, Feb. 25 (Xinhua) -- Zong Qinghou, founder of Hangzhou Wahaha Group, a ... He has long been regarded as one of the landmark figures in Chinese business history.
Edit

TROP-2 Market to Witness Upsurge in Growth During the Study Period (2019-2032), Assesses DelveInsight | ...

GetNews 14 Feb 2024
... PD-L1 inhibitors companies, including Merck, Laekna Therapeutics, Genentech, Tracon Pharmaceuticals Inc., Celgene, MedImmune, Hangzhou Sumgen Biotech, among others ... DelveInsight Business Research LLP.
Edit

CTLA-4 Inhibitors Market to Witness Upsurge in Growth During the Study Period (2019-2032), Assesses DelveInsight ...

GetNews 14 Feb 2024
... PD-L1 inhibitors companies, including Merck, Laekna Therapeutics, Genentech, Tracon Pharmaceuticals Inc., Celgene, MedImmune, Hangzhou Sumgen Biotech, among others ... DelveInsight Business Research LLP.
Edit

HER2+ Inhibitors Market to Witness Upsurge in Growth During the Study Period (2019-32), DelveInsight | ...

GetNews 14 Feb 2024
... PD-L1 inhibitors companies, including Merck, Laekna Therapeutics, Genentech, Tracon Pharmaceuticals Inc., Celgene, MedImmune, Hangzhou Sumgen Biotech, among others ... DelveInsight Business Research LLP.
Edit

PARP Inhibitors Market to Witness Upsurge in Growth During the Study Period (2019-2032), Assesses DelveInsight ...

GetNews 14 Feb 2024
... PD-L1 inhibitors companies, including Merck, Laekna Therapeutics, Genentech, Tracon Pharmaceuticals Inc., Celgene, MedImmune, Hangzhou Sumgen Biotech, among others ... DelveInsight Business Research LLP.
Edit

KRAS Inhibitor Market to Witness Upsurge in Growth During the Study Period (2019-2032), Assesses DelveInsight ...

GetNews 14 Feb 2024
... PD-L1 inhibitors companies, including Merck, Laekna Therapeutics, Genentech, Tracon Pharmaceuticals Inc., Celgene, MedImmune, Hangzhou Sumgen Biotech, among others ... DelveInsight Business Research LLP.
Edit

Debate smoulders over beloved Chinese New Year fireworks tradition

Sierra County Sentinel 08 Feb 2024
Sparklers, rockets and spinning sunflowers with flammable petals --�the fireworks stores in China's Hangzhou are stuffed with treats for pyrotechnic-loving customers, who count themselves lucky to live somewhere they are allowed to set them off.
×